cik stringclasses 1
value | date stringlengths 8 8 | form stringclasses 4
values | sentenceCount int64 0 2.33k | sentence stringlengths 2 5.25k | filename stringlengths 40 40 |
|---|---|---|---|---|---|
0000320193 | 20131030 | 10-K | 1,119 | Note 6 - Long-Term Debt
In May 2013, the Company issued floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $17.0 billion (collectively the “Notes”). | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,120 | The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the floating-rate notes and semi-annually for the fixed-rate notes. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,121 | The principal amounts and associated interest rates of the Notes as of September 28, 2013, are as follows:
The floating-rate notes due 2016 and 2018 bear interest at the three-month London InterBank Offered Rate (“LIBOR”) plus 0.05% and 0.25%, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,122 | To manage the risk of fluctuations in interest rates associated with the floating-rate notes, the Company entered into interest rate swaps with an aggregate notional amount of $3.0 billion designated as cash flow hedges of its floating-rate notes. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,123 | These hedges effectively convert the floating interest rate on the floating-rate notes to a fixed interest rate. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,124 | The gains and losses related to changes in the fair value of the interest rate swaps are recorded in OCI with a portion reclassified to interest expense each period to offset changes in interest rates on the floating-rate notes. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,125 | The effective rates for the Notes include the interest on the Notes, amortization of the discount and, if applicable, adjustments related to hedging. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,126 | The Company recognized $136 million of interest expense for the year ended September 28, 2013. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,127 | As of September 28, 2013, the aggregate unamortized discount for the Company’s Notes was $40 million. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,128 | Future principal payments for the Company’s Notes as of September 28, 2013, are as follows (in millions):
As of September 28, 2013, the fair value of the Company’s Notes, based on Level 2 inputs, was $15.9 billion. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,129 | Note 7 - Shareholders’ Equity
Preferred Stock
The Company has five million shares of authorized preferred stock, none of which is issued or outstanding. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,130 | Under the terms of the Company’s Restated Articles of Incorporation, the Board of Directors is authorized to determine or alter the rights, preferences, privileges and restrictions of the Company’s authorized but unissued shares of preferred stock. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,131 | Dividend and Stock Repurchase Program
The Company declared and paid cash dividends per common share during the periods presented as follows:
The Company paid cash dividends of $2.65 per share, totaling $2.5 billion, during the fourth quarter of 2012. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,132 | Future dividends are subject to declaration by the Board of Directors. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,133 | In 2012, the Company’s Board of Directors authorized a program to repurchase up to $10 billion of the Company’s common stock beginning in 2013. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,134 | In April 2013, the Company’s Board of Directors increased the share repurchase program authorization from $10 billion to $60 billion, of which $23.0 billion had been utilized
as of September 28, 2013. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,135 | The Company’s share repurchase program does not obligate it to acquire any specific number of shares. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,136 | Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,137 | In August 2012, the Company entered into an accelerated share repurchase arrangement (“ASR”) with a financial institution to purchase up to $1.95 billion of the Company’s common stock in 2013. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,138 | In the first quarter of 2013, 2.6 million shares were initially delivered to the Company. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,139 | In April 2013, the purchase period for the ASR ended and an additional 1.5 million shares were delivered to the Company. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,140 | In total, 4.1 million shares were delivered under the ASR at an average repurchase price of $478.20 per share. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,141 | The shares were retired in the quarters they were delivered, and the up-front payment of $1.95 billion was accounted for as a reduction to shareholders’ equity in the Company’s Consolidated Balance Sheet in the first quarter of 2013. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,142 | In April 2013, the Company entered into a new ASR program with two financial institutions to purchase up to $12 billion of the Company’s common stock. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,143 | In exchange for up-front payments totaling $12 billion, the financial institutions committed to deliver shares during the ASR’s purchase periods, which will end during 2014. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,144 | The total number of shares ultimately delivered, and therefore the average price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted average price of the Company’s stock during that period. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,145 | During the third quarter of 2013, 23.5 million shares were initially delivered to the Company and retired. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,146 | This does not represent the final number of shares to be delivered under the ASR. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,147 | The up-front payments of $12 billion were accounted for as a reduction to shareholders’ equity in the Company’s Consolidated Balance Sheet. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,148 | The Company reflected the ASRs as a repurchase of common stock for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,149 | The forward contracts met all of the applicable criteria for equity classification, and, therefore, were not accounted for as derivative instruments. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,150 | During 2013, the Company repurchased 19.4 million shares of its common stock in the open market at an average price of $464.11 per share for a total of $9.0 billion. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,151 | These shares were retired upon repurchase. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,152 | Note 8 - Comprehensive Income
Comprehensive income consists of two components, net income and other comprehensive income. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,153 | Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,154 | The Company’s other comprehensive income consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges, and unrealized gains and losses on marketable s... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,155 | The following table shows the components of AOCI, net of taxes, as of September 28, 2013 and September 29, 2012 (in millions):
Note 9 - Benefit Plans
Stock Plans
2003 Employee Stock Plan
The 2003 Employee Stock Plan (the “2003 Plan”) is a shareholder approved plan that provides for broad-based equity grants to employee... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,156 | The 2003 Plan permits the granting of incentive stock options, nonstatutory stock options, RSUs, stock appreciation rights, stock purchase rights and performance-based awards. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,157 | Options granted under the 2003 Plan generally expire seven to ten years after the grant date and generally become exercisable over a period of four years, based on continued employment, with either annual, semi-annual or quarterly vesting. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,158 | RSUs granted under the 2003 Plan generally vest over two to four years, based on continued employment and are settled upon vesting in shares of the Company’s common stock on a one-for-one basis. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,159 | Each share issued with respect to an award granted under the 2003 Plan (other than a stock option or stock appreciation right) reduces the number of shares available for grant under the plan by two shares, whereas shares issued in respect of an option or stock appreciation right count against the number of shares avail... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,160 | All RSUs, other than RSUs held by the Chief Executive Officer, granted under the 2003 Plan have dividend equivalent rights (“DER”), which entitle holders of RSUs to the same dividend value per share as holders of common stock. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,161 | DER are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,162 | DER are accumulated and paid when the underlying shares vest. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,163 | As of September 28, 2013, approximately 28.3 million shares were reserved for future issuance under the 2003 Plan. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,164 | 1997 Director Stock Plan
The 1997 Director Stock Plan (the “Director Plan”) is a shareholder approved plan that (i) permits the Company to grant awards of RSUs or stock options to the Company’s non-employee directors, (ii) provides for automatic initial grants of RSUs upon a non-employee director joining the Board of D... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,165 | Each share issued with respect to RSUs granted under the Director Plan reduces the number of shares available for grant under the plan by two shares. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,166 | The Director Plan expires November 9, 2019. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,167 | All RSUs granted under the Director Plan are entitled to DER. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,168 | As of September 28, 2013, approximately 176,000 shares were reserved for future issuance under the Director Plan. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,169 | Rule 10b5-1 Trading Plans
During the fourth quarter of 2013, executive officers Timothy D. Cook, Peter Oppenheimer, D. Bruce Sewell, Philip W. Schiller, Daniel Riccio and Jeffrey E. Williams and director William V. Campbell had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,170 | An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,171 | Employee Stock Purchase Plan
The Employee Stock Purchase Plan (the “Purchase Plan”) is a shareholder approved plan under which substantially all employees may purchase the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,172 | An employee’s payroll deductions under the Purchase Plan are limited to 10% of the employee’s compensation and employees may not purchase more than $25,000 of stock during any calendar year. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,173 | As of September 28, 2013, approximately 1.8 million shares were reserved for future issuance under the Purchase Plan. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,174 | 401(k) Plan
The Company’s 401(k) Plan (the “401(k) Plan”) is a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,175 | Under the 401(k) Plan, participating U.S. employees may defer a portion of their pre-tax earnings, up to the IRS annual contribution limit ($17,500 for calendar year 2013). | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,176 | The Company matches 50% to 100% of each employee’s contributions, depending on length of service, up to a maximum 6% of the employee’s eligible earnings. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,177 | The Company’s matching contributions to the 401(k) Plan were $135 million, $114 million and $90 million in 2013, 2012 and 2011, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,178 | Restricted Stock Units
A summary of the Company’s RSU activity and related information for 2013, 2012 and 2011, is as follows:
The fair value as of the respective vesting dates of RSUs was $3.1 billion, $3.3 billion and $1.5 billion for 2013, 2012 and 2011, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,179 | The majority of RSUs that vested in 2013, 2012 and 2011 were net-share settled such that the Company withheld shares with value equivalent to the employees’ minimum statutory obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,180 | The total shares withheld were approximately 2.2 million, 2.3 million and 1.6 million for 2013, 2012 and 2011, respectively, and were based on the value of the RSUs on their respective vesting dates as determined by the Company’s closing stock price. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,181 | Total payments for the employees’ tax obligations to taxing authorities were $1.1 billion, $1.2 billion and $520 million in 2013, 2012 and 2011, respectively, and are reflected as a financing activity within the Consolidated Statements of Cash Flows. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,182 | These net-share settlements had the effect of share repurchases by the Company as they reduced and retired the number of shares that would have otherwise been issued as a result of the vesting and did not represent an expense to the Company. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,183 | Stock Options
A summary of the Company’s stock option activity and related information for 2013, 2012 and 2011, is as follows:
Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the period in excess of the weighted-average exercise price multiplied by the numb... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,184 | Total intrinsic value of options at time of exercise was $1.0 billion, $2.3 billion and $2.6 billion for 2013, 2012 and 2011, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,185 | Share-based Compensation
The Company granted 8,000 and 1,370 stock options during 2013 and 2011, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,186 | The weighted-average grant date fair value per share of stock options granted during 2013 and 2011 was $294.84 and $181.13, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,187 | The Company did not grant any stock options during 2012. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,188 | During 2013 and 2012, in conjunction with certain business combinations, the Company assumed 29,000 and 41,000 stock options, respectively, which had a weighted-average fair value per share of $407.80 and $405.39, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,189 | The Company did not assume any stock options during 2011. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,190 | The weighted-average fair value of stock purchase rights per share was $115.19, $108.44 and $71.47 during 2013, 2012 and 2011, respectively. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,191 | The following table shows a summary of the share-based compensation expense included in the Consolidated Statements of Operations for 2013, 2012 and 2011 (in millions):
The income tax benefit related to share-based compensation expense was $816 million, $567 million and $467 million for 2013, 2012 and 2011, respectivel... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,192 | As of September 28, 2013, the total unrecognized compensation cost related to outstanding stock options and RSUs was $4.7 billion, which the Company expects to recognize over a weighted-average period of 3.0 years. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,193 | Note 10 - Commitments and Contingencies
Accrued Warranty and Indemnification
The Company offers a basic limited parts and labor warranty on its hardware products. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,194 | The basic warranty period for hardware products is typically one year from the date of purchase by the end-user. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,195 | The Company also offers a 90-day basic warranty for its service parts used to repair the Company’s hardware products. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,196 | The Company provides currently for the estimated cost that may be incurred under its basic limited product warranties at the time related revenue is recognized. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,197 | Factors considered in determining appropriate accruals for product warranty obligations include the size of the installed base of products subject to warranty protection, historical and projected warranty claim rates, historical and projected cost-per-claim, and knowledge of specific product failures that are outside o... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,198 | The Company assesses the adequacy of its pre-existing warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,199 | The following table shows changes in the Company’s accrued warranties and related costs for 2013, 2012 and 2011 (in millions):
The Company generally does not indemnify end-users of its operating system and application software against legal claims that the software infringes third-party intellectual property rights. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,200 | Other agreements entered into by the Company sometimes include indemnification provisions under which the Company could be subject to costs and/or damages in the event of an infringement claim against the Company or an indemnified third-party. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,201 | However, the Company has not been required to make any significant payments resulting from such an infringement claim asserted against it or an indemnified third-party and, in the opinion of management, does not have a potential liability related to unresolved infringement claims subject to indemnification that would m... | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,202 | Therefore, the Company did not record a liability for infringement costs related to indemnification as of either September 28, 2013 or September 29, 2012. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,203 | The Company has entered into indemnification agreements with its directors and executive officers. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,204 | Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such
individuals in connection with related legal proceedings. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,205 | It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,206 | However, the Company maintains directors and officers liability insurance coverage to reduce its exposure to such obligations, and payments made under these agreements historically have not been material. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,207 | Concentrations in the Available Sources of Supply of Materials and Product
Although most components essential to the Company’s business are generally available from multiple sources, a number of components are currently obtained from single or limited sources. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,208 | In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,209 | Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that can materially adversely affect the Company’s financial condition and operating results. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,210 | The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,211 | When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,212 | If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,213 | The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,214 | Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers concentrated on the production of common components instead of components customized to meet the Company’s requirements. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,215 | The Company has entered into various agreements for the supply of components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,216 | Therefore, the Company remains subject to significant risks of supply shortages and price increases that can materially adversely affect its financial condition and operating results. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,217 | Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia. | 0001193125-13-416534/full-submission.txt |
0000320193 | 20131030 | 10-K | 1,218 | A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. | 0001193125-13-416534/full-submission.txt |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.